Molecular Biomarkers in Cancer Detection and Monitoring of Therapeutics: Volume 2: Diagnostic and Therapeutic Applications

Molecular Biomarkers in Cancer Detection and Monitoring of Therapeutics: Volume Two: Diagnostic and Therapeutic Applications discusses how molecular biomarkers are used to determine predisposition, facilitate detection, improve treatment and offer prevention guidelines for different cancers. It focuses on novel diagnostic techniques based on molecular biomarkers and their impact on treatment, covering different cancer types such as tumors in the nervous system, head and neck, oral and GI tractor, lung, breast, gastric system, leukemia and urogenital tract cancers. For each type, the book discusses the best diagnostic techniques and therapeutic approaches, thus helping readers easily identify the best solution for each case. This is a valuable resource for cancer researchers, oncologists, graduate students and other members of the biomedical field who are interested in the potential of biomarkers in cancer research. Provides up-to-date information on current molecular biomarkers research for cancer Presents new diagnostic techniques using biomarkers that can leverage quicker results that can be essential for patient's survivorship Discusses several novel therapeutics applied to specific cancer types, such as head and neck, oral, GI tract, breast, lung and hepatocellular carcinomas INDICE: UNIT 1: Tumor invading nervous system 1. Introduction2. Epidemiology3. Signs and symptoms4. Specific Advancements5. Treatment TypesUNIT 2: Head and neck cancer 6. Advances in Screening7. Early detection and treatment strategiesUNIT 3: Oral and GI tract cancers (including Colon ) 8. Incidence9. Etiology and genetic predisposition10. Nutritional impact11. Role of gut microbes12. Diagnostic markers13. Treatment protocols and responseUNIT 4: Lung cancer 14. Predisposition markers including etiological factors15. Diagnostic molecular markers16. Genetic basis of population variations17. Treatment protocols and responseUNIT 5: Cancer affecting upper aero duct 18. Introduction19. p53 and other pathway and targets20. Risk factors associated21. Prognostics22. ConclusionUNIT 6: Leukemias 23. Introduction24. Role of Bcr-Abl and other variants25. Philadelphia translocation: molecular basis and implications26. Epidemiology27. Prognostic markersUNIT 7: Breast and uterine cancer 28. Introduction29. Etiological markers30. Role of estrogen31. Phytoestrogen32. ConclusionUNIT 8: Gastric Cancer 33. Introduction34. Epidemiology35. Predisposition markers36. Signs and symptoms37. Prognostic protocols38. Prevention39. TreatmentUNIT 9: Hepatocellular carcinoma 40. Introduction41. Molecular epidemiology42. Signs and symptoms43. Diagnostic markers44. Prevention45. TreatmentUNIT 10: Human Papilloma Virus in Cervical and other cancers 46. Introduction47. Molecular aspects of HPV including screening technologies48. Etiological aspects49. Signs and symptoms of cancers associated with HPV50. Prevention51. Treatments available including vaccinesUNIT 11: Urogenital Tract Cancers 52. Bladder53. Kidney54. Prostate55. Testicular56. Ovarian57. Molecular markers in their predisposition diagnosis, etiological factors, and treatment protocols and treatment responsesUNIT 12: Rare cancers catching up with common cancers: A case of biliary tract cancer genetics with special emphasis on Gallbladder carcinoma UNIT 13: Molecular Pathogenesis of Gallbladder Cancer: Translational Implications UNIT 14: Assessing role of GWAS identified various mutations, e.g. 5p15.33 and 8q24.21 genetic variants in gallbladder cancer 58. Predisposition59. Treatment response and60. Toxicity in North-Indian population

• ISBN: 978-0-323-95114-2
• Editorial: Academic Press
• Encuadernacion: Rústica
• Páginas: 500
• Fecha Publicación: 01/09/2022
• Nº Volúmenes: 1
• Idioma: Inglés